Research Programs

Fundamental basic laboratory, clinical, and population research are the foundation for all of Karmanos Cancer Institute's Research Programs, which are ultimately directed toward the prevention, early detection or treatment of cancer.

Our Programs include: Tumor Biology and Microenvironment (TBM), Molecular Imaging (MI), Molecular Therapeutics (MT) and Population Studies and Disparities Research (PSDR).

The cancer focus is comprehensive, and encompasses etiology, epidemiology, and prevention, early detection (particularly focused on minority populations), basic and translational research, clinical care (based upon multidisciplinary teams) and clinical research (including investigator-initiated and cooperative group clinical trials).

Other Karmanos Programs

The Latest From Karmanos Cancer Institute

News

IN THE NEWS: Searching for support

Cancer Wellness "The Karmanos Men's Support Group is now like a family to me that meets all my criteria," said Robert Brooks, a multiple myeloma s...

Read More

Karmanos Cancer Institute first to receive innovative, FDA-approved SoftVue™ Breast Imaging System

The Barbara Ann Karmanos Cancer Institute , the world-renowned, Detroit-based National Cancer Institute-Designated Comprehensive Cancer Center, is...

Read More

Hayley Thompson, Ph.D., recognized for her work with LGBT community

"...to be acknowledged by LGBT Detroit for community service is incredibly meaningful."   LGBT Detroit, an organization that works to increas...

Read More
News

ACS CAN Michigan Candid Connection, June 2022 - Cancer Survivorship

Listen Now

How a preemptive cancer screening helped save this doctor’s life

Listen Now

Eliminating health disparities around multiple myeloma

Listen Now